Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation

Lignende værker

• Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?
  af: Zeidan, Amer M., et al.
  Udgivet: (2018)
• Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): A large propensity score-matched population-based study
  af: Davidoff, Amy J., et al.
  Udgivet: (2019)
• Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic Leukemia in the United States: A large population-based study
  af: Zeidan, Amer M., et al.
  Udgivet: (2017)
• The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera
  af: Podoltsev, Nikolai A., et al.
  Udgivet: (2018)
• Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life
  af: Wang, Rong, et al.
  Udgivet: (2017)